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In this issue of Chemistry & Biology, Grossman et al. report a study on aldosterone-dependent nuclear trans-
location of the mineralocorticoid receptor (MR). They analyze the dependency of MR retrotransport, DNA-
binding, and transcriptional activity on Hsp90 and demonstrate that MR dimerization is a nuclear event.Soluble protein transport is a fundamental
mechanism for regulating both protein
localization and protein function of a great
number of factors related to signaling
cascades. Therefore, it is not surprising
that several pathologies leading to cell
death, cell proliferation, or cancer are
directly related to protein mislocalization.
It is currently accepted that most soluble
proteins are not confined to the cyto-
plasm or the nucleus in a static manner
but are capable of shuttling dynamically
through the nuclear pore (Heitzer et al.,
2007). In this sense, steroid-receptors
are excellent tools to dissect this mecha-
nism because their localization may easily
be regulated by adding or washing-out
the steroid.
In the absence of ligand, some mem-
bers of the steroid-receptor family such
as the glucocorticoid receptor (GR) or
MR reside primarily in the cytoplasm,
whereas others are constitutively nuclear,
for example, the estrogen receptor (Pratt
et al., 2004). Regardless of their primary
localization, all of them form oligomers
with the chaperones Hsp90 and Hsp70,
the co-chaperone p23, and proteins that
possess tetratricopeptide repeat (TPR)
sequences of 34 amino-acids repeated
in tandem, the TPR proteins (Galigniana
et al., 2010a). To date, the high molecular
weight immunophilins FKBP52, FKBP51,
and CyP40, and the immunophilin-like
proteins PP5 and XAP2 are counted
among the best characterized members
of the TPR-domain family of proteins
associated to factors of the nuclear
receptor family (Pratt et al., 2004).
It has always been assumed that the
driving force of movement for steroid-
receptors is diffusion. The classical model
was posited some time ago (Dahmer
et al., 1984) and supported the heuristic
notion that the receptor-chaperone heter-662 Chemistry & Biology 19, June 22, 2012 ªocomplex is dissociated immediately
after steroid binding (a process referred
to as ‘‘transformation’’). Therefore, trans-
formation favors the release of the re-
ceptor from the cytoplasmic anchoring
sites and permits its cytoplasmic diffusion
and subsequent passage through the
nuclear pore complex. Thus, the receptor
reaches its nuclear sites of action. None-
theless, the recent observation that the
dynein/dynactin motor complex associ-
ates with the Hsp90-FKBP52 complex
bound to GR and MR suggested that
this motor protein complex could power
the active retrograde movement of
steroid-receptors (Echeverrı´a et al.,
2009; Galigniana et al., 2010b). If this is
correct, the Hsp90-FKBP52 complex
should play a significant role when it is still
associated to the receptor.
While FKBP52, CyP40, and PP5 are
redundant immunophilins in their ability
to interact with dynein/dynactin (Pratt
et al., 2004), FKBP51 is a poor interactor
and is also an effective transcriptional
inhibitor (Gallo et al., 2007). Therefore, it
is not surprising that upon steroid binding,
FKBP51 is released from the receptor
complex and replaced by FKBP52, which
in turn recruits dynein/dynactin (Figure 1).
This immunophilin exchange assembles
the molecular machinery for the efficient
retrotransport of the steroid-receptor
complex. Further studies demonstrated
that Hsp90 is still part of the heterocom-
plex when MR is nuclear. Moreover, the
entire Hsp90 heterocomplex cross-linked
to either GR (Echeverrı´a et al., 2009) or
MR (Galigniana et al., 2010b) trans-
locates intact through the nuclear pore
of digitonin-permeabilized cells, suggest-
ing that steroid-receptor transformation
could be a nuclear event. Accordingly,
members of the chaperone heterocom-
plex are able to interact with structures2012 Elsevier Ltd All rights reservedof the nuclear pore such as nucleoporins
and importins (Echeverrı´a et al., 2009).
This alternative mechanism of action
differs from the classical model in that
Hsp90 does not have to dissociate from
the receptor to initiate its nuclear translo-
cation. Actually, Hsp90 is required for
this process (Galigniana et al., 2010a).
Accordingly, it has also been suggested
that GR homodimerization is nuclear
(Presman et al., 2010). Nonetheless, sev-
eral aspects of this model need further
confirmation and some steps are still to
be proven. Because the dimerization
domain of the receptors is blocked by
the Hsp90 complex, it is valid to wonder
whether receptor dimerization is a nuclear
event or whether it paves the way to favor
the nuclear translocation of the receptor.
In turn, DNA-binding experiments favor a
model involving early dimerization prior
to DNA-binding rather than consecutive
binding of monomers (Segard-Maurel
et al., 1996), which is also in agreement
with the lower affinity of monomers for
DNA (Tsai and O’Malley, 1994). One may
also wonder whether this alternative
mechanism is common for all members
of the steroid-receptor family.
To date, some of the answers to these
questions were indirect extrapolations
that deserved a more convincing experi-
mental demonstration. In this issue of
Chemistry & Biology, Grossman et al.
(2012) have addressed this biological
conundrum and have elegantly confirmed
those previous studies. In addition, the
study also proves the accuracy of the
alternative model. The authors report
that during aldosterone-induced nuclear
translocation, MR is still bound to
Hsp90, and by using extended biolumi-
nescence resonance energy transfer and
fluorescence resonance energy transfer,
it is univocally demonstrated that MR
Figure 1. Model of MR Activation
In the absence of ligand, MR exists in the cytoplasm associated to the Hsp90-
based heterocomplex. Upon aldosterone binding, the immunophilin FKBP51 is
exchanged by FKBP52, an immunophilin able to bind dynein/dynactin. Thus,
the MR heterocomplex is transported toward the nucleus via the motor protein
complex. Then, MR translocates to the nucleoplasm still associated to the
Hsp90 heterocomplex, and MR transformation occurs in the nuclear compart-
ment followed by MR homodimerization. The receptor is finally targeted to the
promoter binding-sites to trigger the proper biological response. When the anti-
mineralocorticoid spironolactone binds,MR transformation andMRhomodime-
rization can also take place in the cytoplasm, but the steroid-receptor complex
translocation to the nucleus is impaired. It should be emphasized that FKBP51
is a very weak dynein-interacting protein and is also a strong transcriptional
inhibitor of MR. Yellow arrows represent active transport of the MR complex.
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Previewshomodimerization is a nuclear
process. After optimizing
the proper amounts of trans-
fected enhanced yellow-
green fluorescent protein
MR, it is shown that aldoste-
rone, but not spironolactone,
causes a significant nuclear
MR-MR homodimerization,
such that the MR remains
cytoplasmic with the antimi-
neralocorticoid. On the other
hand, cell treatment with
the Hsp90-disrupting agent
geldanamycin shows that
MR homodimerization takes
place even in the absence of
ligandwhen Hsp90 is dissoci-
ated from the receptor in the
cytoplasm. However, Hsp90
inhibition prevents the
nuclear translocation of the
MR and it partially inhibits
DNA-binding of MR. Interest-
ingly, this inhibition is less
efficient for GR. This dissimi-
larity could contribute to the
mechanism by which MR
differs from GR in those cells
where both receptors recog-nize equal hormone-response elements.
Importantly, only homodimers formed in
the nucleus regulate gene expression,
whereas those formed in the cytoplasm
do not possess the ability to translocate
to the nucleus and consequently influence
transactivation.
These findings by Grossman et al.
(2012) clarify mechanistic aspects of the
MR signaling, although some aspectsremain unknown. In this regard, the
overall elucidation of the nuclear-cyto-
plasmic mechanism of steroid-receptor
shuttling prompts the subsequent search
for new potential partners of the receptor
as well as for active drugs that can
influence receptor relocalization. This will
contribute to development of new strate-
gies for preventing the pathophysiological
effects of steroid hormones.Chemistry & Biology 19, June 22, 2012 ª2012 ElseREFERENCES
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